GRX Gabelli Healthcare & WellnessRx Trust Insider Trading

Director Gabelli purchased 4,810 shares at $9.58 across 2 transactions, nearly doubling stake to 10,000 shares

Director Mario J Gabelli executed 2 separate purchases totaling 4,810 shares for $46,079.80 on 2026-01-12, increasing his holdings from 5,190 shares to 10,000 shares—a 92.7% increase in position size. The shares were purchased at $9.58, slightly below the current price of $9.61, placing the execution near the recent 30-day trading window (+1.8% change) and well below the 52-week high of $10.42. His cross-ticker track record shows 20 prior buys with an average 30-day return of -0.2%, while his prior two purchases at GRX (most recent on 2026-01-08 and 2025-12-03) have mixed measurable outcomes, with the December transaction showing a -0.5% 30-day return. The significant share accumulation at a measured price point warrants attention to whether this represents a material shift in the director's conviction at this specific holding.

Director Gabelli buys 990 shares of GRX at $9.58, raising stake to 9.0K shares; stock currently $9.57.

Director Mario J Gabelli purchased 990 shares at $9.58 on 2026-01-08, increasing his holdings from 8,000 shares to 9.0K shares, representing a +12.4% increase in position size. The transaction occurred at a price near the current market level of $9.57, and within the 52-week range of $8.96–$10.42. His cross-ticker track record shows 20 prior open-market buys averaging -0.2% 90-day returns, while his three prior GRX trades (including two subsequent buys on 2026-01-12) show limited measurable outcomes, with one prior buy on 2025-12-03 posting a -0.5% 30-day return. The transaction size is modest at $9,484.20 and represents a discrete addition rather than a concentrated directional move in the fund.

Director Gabelli buys 1,800,000 shares at $10.00 in 4 transactions for $18,000,000.00

Director Mario J Gabelli executed 4 separate purchases totaling 1,800,000 shares for $18,000,000.00 at $10.00 per share on 2025-12-26, moving his holdings from -1,700,000 shares to 100,000 shares post-transaction. This substantial $18.0M deployment represents a significant capital commitment on a single trading day at a consistent price point. Gabelli's cross-ticker track record shows 20 prior open-market buys with an average 90-day return of +4.7% and a 66.67% win rate, providing historical context for his pattern of identifying entry points, though this metric reflects performance across multiple holdings rather than specific performance at GRX.E.

Director Gabelli buys 100,000 shares of GRX.G at $10.00 for $1,000,000.00; holdings reach 1.50M shares

Mario J Gabelli, a Director, purchased 100,000 shares (100.0K shares) of Gabelli Healthcare & WellnessRx Trust at $10.00 on 2025-12-26, increasing his holdings from 1.40M shares to 1.50M shares. This represents a 7.1% increase in his position size. Notably, Gabelli's cross-ticker track record shows 20 prior buys with an average 90-day return of -2.0%, indicating a pattern of purchasing near local peaks or ahead of price declines. At GRX.G specifically, this is only the second open-market transaction visible in the SAME-TICKER HISTORY, following a buy on 2025-10-30 whose outcome remains unmeasurable. The absence of measurable outcomes on prior trades at this ticker limits direct assessment of his execution timing in this fund, though the negative cross-ticker average suggests caution.

Saba Capital, 10% owner of GRX, bought 15,396 shares across 2 transactions for $144,219.68 at blended $9.37

Saba Capital Management, L.P. executed two separate purchases totaling 15,396 shares for $144,219.68 at a blended average price of $9.37 on December 16–17, 2025, increasing its post-transaction holdings to 2,118,201 shares. The purchases occurred near the lower end of the 52-week range ($8.96–$10.42) and within 9.3% of the 52-week high, with the current price at $9.45 now trading modestly above the transaction average. This represents a continuation of Saba Capital's pattern, which shows 20 prior open-market buys across all tickers in its track record. The magnitude of this addition—0.7% relative to pre-transaction holdings—reflects a modest accumulation by an already-substantial stakeholder, warranting attention to whether this signals sustained conviction in the fund's positioning.

Director Gabelli buys 2,500 shares of GRX at $9.69; stock down 9.5% from 52-week high, but up 3.9% in 30 days.

Director Mario J. Gabelli purchased 2,500 shares at $9.69, increasing his holdings to 239,425 shares (+1.1% vs pre-transaction holdings). The stock currently trades at $9.53, roughly -9.5% from its 52-week high of $10.53, though it has recovered +3.9% over the past 30 days. Gabelli's prior four purchases at GRX show a mixed pattern: 3 of 4 trades resulted in negative 90-day returns, with only the 2024-12-31 buy generating a +3.9% 90-day gain. His broader cross-ticker track record of 20 buys reflects a 41.67% 90-day win rate with an average 90-day return of -1.8%, indicating his buy timing has not historically been reliable across holdings. The modest purchase size and his substantial existing position suggest ongoing participation in the trust rather than a material conviction signal.

Saba Capital acquired 14,451 shares of GRX at $9.62; stake now 2,102,805 shares

Saba Capital Management purchased 14,451 shares at $9.62 on 2025-11-25, bringing its total holdings to 2,102,805 shares. The buy represents a 0.7% increase relative to pre-transaction holdings and is consistent with the insider's prior pattern: across all open-market activity, Saba shows 14 prior buys against 6 prior sells, indicating a net accumulation behavior. The current price of $9.60 is near the transaction level and -8.8% from the 52-week high of $10.53, placing the acquisition within the lower portion of the recent trading range. No fundamental data or scheduled transaction FLAGS are present in the filing, so this appears to be a discretionary market purchase by a significant shareholder.

Director Mario Gabelli bought 1,800,000 shares of GRX.G at $10.18 ($18.3M), raising stake 900% to 2,000,000 shares

GABELLI MARIO J, a director, executed a substantial open-market purchase of 1,800,000 shares at $10.18 on 2025-10-30, investing $18,322,380.00 and expanding his holdings from 200,000 shares to 2,000,000 shares—a 900% increase in position size. This represents a material escalation of personal capital commitment to Gabelli Healthcare & WellnessRx Trust, shifting him from a minor to a major shareholder. His cross-ticker trading history shows 20 prior buys with a 90-day win rate of 42.86% and an average 90-day return of -1.4%, indicating his prior open-market purchases have not reliably outperformed the market; this transaction's outcome will be measurable against that baseline.

Saba Capital bought 20,808 shares of GRX at $9.28 on 2025-10-23, fourth consecutive daily purchase, holdings now 2,088,354 shares

Saba Capital Management executed its fourth consecutive day of purchases in Gabelli Healthcare & WellnessRx Trust, acquiring 20,808 shares at $9.28 and bringing total holdings to 2,088,354 shares. This represents continued accumulation at prices near the 52-week low of $8.96, with the stock currently trading -13.2% below its 52-week high of $10.66. The 30-day price performance shows +2.7% gains, yet the concentrated buying activity over a four-day span (2025-10-16 through 2025-10-23) within a narrow price band suggests systematic purchasing activity rather than opportunistic single trades. The pattern warrants observation to determine whether this represents sustained conviction or temporary tactical positioning.

Saba Capital, 10% owner of GRX, bought 7,175 shares across 2 transactions for $66,676.81 at blended $9.29

Saba Capital Management purchased 7,175 shares in two transactions on 2025-10-21 and 2025-10-22 at an average price of $9.29, increasing holdings from 2,060,371 to 2,067,546 shares—a +0.3% net change. The current price stands at $9.31, only 0.2% above the blended transaction price, and the stock is -13.5% from its 52-week high of $10.76. While Saba's cross-ticker track record shows 20 prior buys averaging +19.0% returns over 30 days, this ticker-specific activity at GRX cannot yet be assessed for outcomes, with three prior GRX purchases all recent and unmeasurable at the 30- and 90-day marks. The modest 0.3% increase in a 2.07M-share position represents a small, incremental accumulation rather than a material shift in conviction or exposure.